Article Details

FogPharma collects $66M to advance cell-penetrating cancer inhibitor

Retrieved on: 2018-05-15 22:26:15

Tags for this article:

Click the tags to see associated articles and topics

FogPharma collects $66M to advance cell-penetrating cancer inhibitor. View article details on hiswai:

Excerpt

<div>... alongside new investors Blue Pool Capital, Horizons Ventures, Nan Fung Group, Leerink Partners and GV, formerly known as <b>Google Ventures</b>.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up